# Intensive Blood PRessure Control in Patients With Acute Type B AortIc Dissection

> **NCT03001739** · PHASE1 · UNKNOWN · sponsor: **Sir Run Run Shaw Hospital** · enrollment: 360 (estimated)

## Conditions studied

- Blood High Pressure
- Aortic Dissection Type B

## Interventions

- **DRUG:** Urapidil Hydrochloride Injection

## Key facts

- **NCT ID:** NCT03001739
- **Lead sponsor:** Sir Run Run Shaw Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-12
- **Primary completion:** 2018-12
- **Final completion:** 2019-07
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2016-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03001739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03001739, "Intensive Blood PRessure Control in Patients With Acute Type B AortIc Dissection". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03001739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*